FN Q1 2026 Earnings Slight EPS Beat Amid Stable Performance CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting BLX Q1 2026 Earnings Earnings Per Share Reported at 131 Shares Dip 227 Saratoga Investment Corp 750 Notes due 2031 SAV Q1 2026 Earnings Substantial EPS Miss Weighs on Investor Sentiment LPA Q1 2026 Earnings Negative EPS of 025 Amid Unreported Revenue Stock Falls 74